Natixis Advisors LLC Sells 2,903 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Natixis Advisors LLC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 107,202 shares of the company’s stock after selling 2,903 shares during the period. Natixis Advisors LLC’s holdings in HCA Healthcare were worth $32,177,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. GSA Capital Partners LLP purchased a new position in shares of HCA Healthcare during the 3rd quarter worth $567,000. CIBC Asset Management Inc boosted its stake in shares of HCA Healthcare by 4.9% during the 3rd quarter. CIBC Asset Management Inc now owns 29,427 shares of the company’s stock worth $11,960,000 after acquiring an additional 1,362 shares during the last quarter. Atlanta Consulting Group Advisors LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth $311,000. Planning Directions Inc. purchased a new position in shares of HCA Healthcare during the 3rd quarter worth $236,000. Finally, Quest Partners LLC boosted its stake in shares of HCA Healthcare by 384.9% during the 3rd quarter. Quest Partners LLC now owns 3,171 shares of the company’s stock worth $1,289,000 after acquiring an additional 2,517 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $319.82 on Monday. The company has a 50 day moving average price of $319.00 and a 200-day moving average price of $344.95. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market capitalization of $78.74 billion, a PE ratio of 14.56, a PEG ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the firm posted $5.90 earnings per share. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.90%. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

HCA has been the topic of a number of analyst reports. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Barclays reduced their target price on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Truist Financial reduced their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, KeyCorp cut their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.